Article Text

FRI0286 Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. a subgroup analysis.
  1. M. U. Martinez-Martinez1,
  2. J. Alcocer-Varela2,
  3. F. J. Merayo-Chalico2,
  4. J. D.J.E. Gómez-Bañuelos3,
  5. M. A. Saavedra3,
  6. S. Enciso-Peláez4,
  7. E. Faugier-Fuentes4,
  8. R. Maldonado-Velázquez4,
  9. L. M. Suárez-Larios5,
  10. D. Vega-Morales6,
  11. A. Abril7,
  12. R. Butendieck7,
  13. F. Irazoque-Palazuelos8,
  14. C. Abud-Mendoza1
  1. 1Hospital Central “Dr. Ignacio Morones Prieto”, San Luis Potosi
  2. 2Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  3. 3Centro Médico Nacional “La Raza”
  4. 4Hospital Infantil de México, Mexico City
  5. 5Hospital Infantil del Estado de Sonora, Sonora
  6. 6Hospital Universitario de Nuevo León, Nuevo León, Mexico
  7. 7Mayo Clinic, Jacksonville, United States
  8. 8Hospital 20 de Noviembre ISSSTE, Mexico City, Mexico


Background Diffuse alveolar hemorrhage (DAH) is a rare life-threatening complication in systemic lupus erythematosus (SLE). It is associated with a high mortality rate. Pathogenesis of DAH in patients with SLE includes disease activity; however, infection was demonstrated in more than 50% in other case series.

Objectives To evaluate subgroups in a large retrospective cohort of SLE patients with DAH.

Methods This retrospective cohort included 57 patients with SLE and DAH from 8 hospitals. We evaluated clinical, laboratory and treatment data. All patients met the American College of Rheumatology classification criteria for SLE. DAH was defined according to the presence of sudden drop of hemoglobin of at least 1.5 g/dL without other sources of bleeding, new infiltrates on chest radiograph and at least one of the following pulmonary symptoms: hemoptysis, dyspnea, or tachycardia. Non-parametric statistics were performed; categorical variables were compared with X2 or exact Fisher-test.

Results We included 57 patients with DAH and SLE, 49 (86%) were women, 14 (24.6%) children, and 24 (42.1%) died. Twenty two patients (38.6%) were diagnosed with infection (8 invasive fungal infections, 21 bacterial infections, 7 patients had mixed infections). Factors associated with mortality were: high disease activity (relative risk (RR)=2.1, confidence interval (CI): 1.1-4.1, p=0.0239), glomerular filtration rate less than 60 ml/min/1.72 m2 (RR: 2.5, CI: 1.2-5.1, p=0.0052), mechanical ventilation (RR: 7.5, CI: 1.1-50.5, p-value= 0.002), infections (1.9, CI: 1.03- 3.5, p=0.04) and specifically fungal infections (RR: 2.0, CI: 1.2-3.5, p= 0.04). There were no differences in mortality rates between children and adults. Table 1 shows factors associated with infection, and that SLE treatment naïve as a “protective” factor.

Conclusions DAH in SLE patients is frequently associated with infection; our series describes a subgroup analysis of this rare manifestation of SLE. Factors associated with infection can indicate therapeutic choice for the rheumatologists in SLE patients with DAH.

Disclosure of Interest: None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.